SignatureFD’s Utah Medical Products UTMD Stock Holding History

SignatureFD’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.96K	Hold	67	–	–	﹤0.01%	2938
2026 Q2	$4.62K	Hold	67	–	–	﹤0.01%	2883
2026 Q1	$4.15K	Hold	67	–	–	﹤0.01%	2839
2025 Q4	$3.75K	Buy	+67	New	+$3.88K	﹤0.01%	2793
2024 Q4	–	Sell	-38	Closed	-$2.54K	–	3408
2024 Q3	$2.54K	Hold	38	–	–	﹤0.01%	2774
2024 Q2	$2.54K	Hold	38	–	–	﹤0.01%	2698
2024 Q1	$2.7K	Sell	38 -55	-59%	-$4.12K	﹤0.01%	2720
2023 Q4	$7.83K	Hold	93	–	–	﹤0.01%	2360
2023 Q3	$8K	Buy	93 +38	+69%	+$3.51K	﹤0.01%	2321
2023 Q2	$5.13K	Hold	55	–	–	﹤0.01%	2509
2023 Q1	$5.21K	Hold	55	–	–	﹤0.01%	2495
2022 Q4	$5.53K	Hold	55	–	–	﹤0.01%	2429
2022 Q3	$5K	Hold	55	–	–	﹤0.01%	2471
2022 Q2	$5K	Sell	55 -55	-50%	-$4.69K	﹤0.01%	2467
2022 Q1	$10K	Buy	110 +99	+900%	+$9.1K	﹤0.01%	2177
2021 Q4	$1K	Buy	+11	New	+$1.12K	﹤0.01%	3006
2021 Q2	–	Sell	-7	Closed	-$1K	–	3070
2021 Q1	$1K	Sell	7 -5	-42%	-$440	﹤0.01%	2694
2020 Q4	$1K	Sell	12 -12	-50%	-$1.02K	﹤0.01%	2493
2020 Q3	$2K	Hold	24	–	–	﹤0.01%	2289
2020 Q2	$2K	Hold	24	–	–	﹤0.01%	2198
2020 Q1	$2K	Buy	24 +1	+4%	+$93	﹤0.01%	2016
2019 Q4	$2K	Hold	23	–	–	﹤0.01%	1933
2019 Q3	$2K	Hold	23	–	–	﹤0.01%	1864
2019 Q2	$2K	Buy	23 +12	+109%	+$1.01K	﹤0.01%	1795
2019 Q1	$1K	Sell	11 -1	-8%	-$88	﹤0.01%	1909
2018 Q4	$1K	Buy	12 +2	+20%	+$176	﹤0.01%	1872
2018 Q3	$1K	Sell	10 -4	-29%	-$382	﹤0.01%	1845
2018 Q2	$2K	Hold	14	–	–	﹤0.01%	1749
2018 Q1	$1K	Buy	+14	New	+$1.25K	﹤0.01%	1694

Other funds holding UTMD

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 36.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Quantinno Capital Management New York $106B AUM 29.93% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

SignatureFD's UTMD Position: Q3 2026 in Review

SignatureFD held its Utah Medical Products (UTMD) position steady in Q3 2026 at 67 shares worth $4.96K. The position accounts for ﹤0.01% of the portfolio, ranked #2938.

SignatureFD first reported a position in UTMD in Q1 2018 and has held it in 29 quarters since. The position peaked at $10K in Q1 2022. 95 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.

SignatureFD held 67 shares of Utah Medical Products worth $4.96K as of Q3 2026.
SignatureFD left its Utah Medical Products share count unchanged in Q3 2026.
Utah Medical Products made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2938 holding.
SignatureFD first reported a position in Utah Medical Products in Q1 2018 and has held it in 29 quarters since.
SignatureFD's Utah Medical Products position peaked at $10K in Q1 2022.
95 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.